United States· US:73581-401_4497c67f-376c-7ef0-e063-6294a90ad64a
MUCUS RELIEF
A guaifenesin product containing guaifenesin, registered in United States by YYBA CORP. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Guaifenesin is registered in 14 of 19 countries.
Countries holding a registration under ATC R05CA03 (guaifenesin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Guaifenesin · ATC R05CA03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of guaifenesin costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.
- United States: $0.29 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Guaifenesin · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- US United States$0.29 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GUAIFENESIN
- Manufacturer
- YYBA CORP
- Country
- United States (US)
- ATC code
- R05CA03
- ATC class
- Guaifenesin
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc117358140102200 TABLET in 1 BOTTLE (73581-401-02)
- ndc11735814012020 TABLET in 1 BOTTLE (73581-401-20)
- ndc11735814017070 TABLET in 1 BOTTLE (73581-401-70)
- ndc1173581-401-02
- ndc1173581-401-20
- ndc1173581-401-70
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Guaifenesin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAdult Meltus for Chesty Coughs and Catarrh oral solutionSSL International Plc
- BelgiumBronchosedal Mucus Honing & Citroen 20 mg/mlKenvue Belgium
- CzechiaGUAJACURANZentiva, k.s., Praha
- CanadaBALMINIL EXPECTORANT (SUCROSE FREE)TEVA CANADA LIMITED
- IrelandBenylin Children’s Chesty Cough 50 mg/5 ml SyrupJNTL Consumer Health (Ireland) Limited
- FinlandResyl SNovartis Finland Oy
- SpainFORMULAEXPEC 13,33 mg/ml JARABE SABOR MIELLaboratorios Vicks S.L.
- NorwayBenysineMcNeil Sweden AB
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Bronchostop Akut, Grippostad Guaifenesin
- Belgium · Bronchosedal Mucus Honig & Zitrone, Bronchosedal Mucus Honing & Citroen
- Cyprus · Benylin Mucus Cough Warm Honey & Lemon Flavour
- Czechia · Guajacuran, Medexpecto Vicks Sirup Med A Zázvor
- Germany · Fagusan, Wick Husten-Löser Mit Honigaroma
- Denmark · Benysine
- Estonia · Expexin
- Spain · Formulaexpec, Frispec
- France · Vicks Expectorant Adultes Miel
- United Kingdom (Northern Ireland) · Bell’s Healthcare Mucus Cough, Benylin Children's Chesty Coughs
- Greece · Hexacough Warm Honey & Lemon
- Hungary · Relaxil-G, Robitussin Expectorans
- Ireland · Benylin Children's Chesty Cough, Benylin Mucus Cough Honey & Lemon
- Iceland · Túfen
- Italy · Actigrip Tosse Mucolitico "gusto Mentolo”, Vicks Tosse Fluidificante
- Lithuania · Expexin
- Luxembourg · Bronchosedal Mucus Menthol, Bronchosedal Mucus Miel & Citron
- Latvia · Expexin
- Norway · Benysine Med Honning- Og Sitronsmak, Solvipect
- Poland · Guajazyl, Robitussin Expectorans
- Portugal · Vicks Expectorante Mel
- Romania · Robitussin Expectorans, Vicks Expectorant
- Sweden · Nipenesin, Nipenesin Mentol
- Slovakia · Guajacuran, Robitussin Expectorans Na Vykašliavanie
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afd2e60f-9891-4cc9-9ad4-aff130c45b17 GET /v1/drugs/afd2e60f-9891-4cc9-9ad4-aff130c45b17?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "600",
"substance": "GUAIFENESIN",
"productndc": "73581-401",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213420",
"marketing_category": "ANDA"
}See everything about guaifenesin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.